Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |